share_log

神威药业发盈喜,预计年度股东应占溢利同比增加约30%至36%

Shenwei Pharmaceutical is happy to report that annual profit attributable to shareholders is expected to increase by about 30% to 36% year over year

新浪港股 ·  Mar 7 04:00

Shenwei Pharmaceutical (02877) announced that the profit attributable to the company's owners for the year ended December 31, 2023 is expected to increase by about 30% to 36% compared to the same period last year (2022: about RMB 723 million).

The expected increase in profit attributable to company owners this year is mainly due to an increase in the Group's overall sales revenue of about 14% compared to last year and a decrease of about 2 to 3 percent in the ratio of sales and distribution costs to turnover compared to last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment